SCHWAB STRATEGIC TR 5-10 YEAR CORPORATE BOND ETF SCHI 深 沪
已收盘 02-06 16:00:00 美东时间
23.00
+0.030
+0.13%
华盛通- 最 高23.00
- 今 开22.99
- 成交量 249.80万股
- 最 低 22.95
- 昨 收 22.97
- 总市值 101.13亿
- 52周最高 23.00
- 市盈率 静 --
- 换手率 0.57%
- 52周最低 20.6353
- 委 比 -62.17%
- 总股本 4.40亿
- 历史最高 23.2039
- 量 比 0.75
- 振 幅 0.22%
- 历史最低 16.7789
- 每 手 1
- 风险率 0.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Douglas Cifu And Kenneth Schiciano Elected To MarketAxess Board Of Directors
BRIEF-Douglas Cifu And Kenneth Schiciano Elected To MarketAxess Board Of Directors Jan 26 (Reuters) - Marketaxess Holdings Inc MKTX.O : DOUGLAS CIFU AND KENNETH SCHICIANO ELECTED TO MARKETAXESS BOARD OF DIRECTORS Source text: ID:nBw2KZhxCa Further company coverage: MKTX.O (( Reuters.Briefs@thomsonre
01-26 19:32
BRIEF-Capital One To Acquire Brex
BRIEF-Capital One To Acquire Brex Jan 22 (Reuters) - Capital One Financial Corp COF.N : CAPITAL ONE TO ACQUIRE BREX CAPITAL ONE FINANCIAL CORP - FRANCESCHI TO CONTINUE LEADING BREX POST-ACQUISITION Source text: ID:nBwbRTLp1a Further company coverage: COF.N (( Reuters.Briefs@thomsonreuters.com ;))
01-23 06:32
Schwab 5-10 Year Corporate Bond ETF declares $0.1018 dividend
Schwab 5-10 Year Corporate Bond ETF (SCHI) declared $0.1018/share monthly dividend. Payable Nov. 7; for shareholders of record Nov. 3; ex-div Nov. 3. More on Schwab 5-10 Year Corporate Bond ETF Seekin...
2025-11-03 22:59
美股盘后 | Datadog涨9.40%，瑞穗金融涨3.34%
<p>华盛资讯7月3日消息，美股盘后，三大股指期货涨跌不一，标普500主连$ESmain跌0.00%，道指主连$YMmain涨0.01%，纳指主连 $NQmain跌0.00%。</p><p><strong>今日盘后涨幅TOP5</strong></p><p>Datadog盘后涨9.40%，报147.7美元；</p><p>瑞穗金融盘后涨3.34%，报5.78美元；</p><p>Elevance Health盘后涨2.50%，报359.0美元；消息面上，Elevance Health受到同行业公司Centene于7月2日宣布撤回2025年盈利指引的消息影响，主要原因是医疗补助计划在行为健康、家庭健康和高成本药品等领域的医疗成本呈上升趋势；</p><p>詹姆斯哈迪盘后涨2.01%，报28.92美元；</p><p>Zillow盘后涨1.95%，报72.39美元；消息面上，Zillow于7月2日发布最新研究报告显示，接受宠物的租赁房源在其平台上比不接受宠物的房源平均提前8天出租，此类房源获得9%更
2025-07-03 06:11
Italy - Factors to watch on Jan. 30
The following factors could affect Italian markets on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list ...
2025-01-30 15:16
INSTANT VIEW-Fed stands pat, leans hawkish with omission of inflation-progress reference
Jan 29 (Reuters) - The Federal Reserve left interest rates in the 4.25% to 4.50% target range on Wednesday and gave little insight into when further easing may take place in an economy where inflation...
2025-01-30 03:27
BRIEF-Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia
Jan 17 (Reuters) - Zai Lab Ltd 9688.HK: ZAI LAB ANNOUNCES ACCEPTANCE OF NEW DRUG APPLICATION FOR KARXT FOR THE TREATMENT OF SCHIZOPHRENIA Source text: ID:nBw2NM7cMa Further company coverage: 9688.HK (...
2025-01-17 20:37
BRIEF-Boehringer Provides Update On Iclepertin Phase III Program In Schizophrenia
Jan 16 (Reuters) - BOEHRINGER INGELHEIM: BOEHRINGER PROVIDES UPDATE ON ICLEPERTIN PHASE III PROGRAM IN SCHIZOPHRENIA BOEHRINGER INGELHEIM: PRIMARY AND KEY SECONDARY ENDPOINTS WERE NOT MET Source text:...
2025-01-16 23:12
BRIEF-Target Expects Q4 Comparable Sales Up About 1.5%
Jan 16 (Reuters) - Target Corp TGT.N: TARGET OUTLOOK Q4 COMPARABLE SALES UP ABOUT 1.5% VERSUS IBES ESTIMATE OF GROWTH OF 0.2% TARGET OUTLOOK Q4 ADJUSTED EPS $1.85 TO $2.45 VERSUS IBES ESTIMATE $2.15 T...
2025-01-16 19:30
BRIEF-LB Pharmaceuticals Positive Topline Results From Phase 2 Trial Of Lb-102 In Schizophrenia
Jan 8 (Reuters) - Lb Pharmaceuticals: LB PHARMACEUTICALS: POSITIVE TOPLINE RESULTS FROM PHASE 2 TRIAL OF LB-102 IN SCHIZOPHRENIA LB PHARMACEUTICALS: TRIAL MET PRIMARY ENDPOINT WITH STATISTICALLY SIGNI...
2025-01-08 20:00
